Skip to main navigation Skip to search Skip to main content

Dietary Intervention Trial Design in Patients With an Ileoanal Pouch: Lessons From a Randomized, Double-Blind, Placebo-Controlled Feeding Study

Research output: Contribution to journal › Article › Research › peer-review

Abstract

Purpose: The aims of this study were to assess the effects of a whole diet strategy, a Monash Pouch Diet (MPD), on pouch-related symptoms, inflammation, quality of life, and stool characteristics in a cohort of patients with symptomatic pouches and a history of pouchitis compared with a typical Australian pouch diet. Methods: In this randomized, double-blind, placebo-controlled dietary feeding trial, patients with ileoanal pouches received either a Monash Pouch diet or a typical Australian diet for 7 weeks. Clinical scores (Pouch Disease Activity Index, PDAI), pouch symptoms, tolerability, fecal calprotectin, and quality of life were measured pre- and post-intervention. The primary outcome consisted of the proportion of patients achieving symptomatic remission (clinical PDAI ≤ 2). Results: All patients on the MPD experienced worsening symptoms, and the trial was terminated early. The majority of the participants reported partial adherence (50%–80%) and poor tolerability (median: 40 mm). Quality of life outcomes were highly variable across dietary arms, and fecal indices showed no consistent trends related to diet. Conclusion: This double-blinded, placebo-controlled, dietary feeding trial failed to determine the effect of the Monash Pouch Diet on pouchitis but suggests that the design of dietary trials for pouch patients requires careful consideration.

Original languageEnglish
Article numbere70287
Number of pages4
JournalJGH Open
Volume9
Issue number10
DOIs
Publication statusPublished - Oct 2025

Keywords

  • diet
  • fiber
  • ileoanal pouch
  • J-pouch
  • Monash Pouch Diet
  • sulphide

Cite this